Medtronic PLC vs Peloton Interactive Inc — how do they compare? Medtronic PLC trades at $82.53 (market cap $106.61B), while Peloton Interactive Inc trades at $6.44 (market cap $2.82B). The key difference: Medtronic PLC is far larger — about 37.8× Peloton Interactive Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| MDT | PTON | |
|---|---|---|
Market Cap | $106.61B | $2.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $9.00 |
52-Week Low | $73.75 | $3.71 |
Enterprise Value | $125.36B | $3.42B |
Dividend Yield | 3.46% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Peloton (PTON) trades at $6.545, up 6.94% today, showing stabilization after years of decline. The company achieved positive operating cash flow of $333M in 2025 and is projected to return to net profitability in 2026. Technical indicators are bullish on moving averages, while fundamentals reveal high debt levels but improving margins. Recent news highlights leadership changes and inclusion in the S&P SmallCap 600 index as potential catalysts.
Outlook remains cautious but improving; PTON offers turnaround potential with cost controls driving cash flow, but risks include persistent revenue declines and substantial long-term debt of $1.49B. Analyst consensus is mixed with a $7.50 price target, suggesting modest upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →